InsidersTradesSigma
Strides Pharma Science Limited Stock: price and directors' dealings · India · SEBI (PIT + SAST)
Follow the Strides Pharma Science Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Strides Pharma Science Limited has recorded 39 public disclosures. Market capitalisation: €61.7bn. The latest transaction was filed on 24 March 2022 (Purchase). Among the most active insiders: Pronomz Ventures LLP. All data is openly available.
39
Insider Decl.
0
Thresholds
€4m
23 ops.
Buy Volume
€3m
16 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,774 of 26,212 companies
65.7
score / 100
Value58
Quality73
FCF yld2.9%
Earn yld5.6%
EV/EBITDA11.2x
ROE20%
Gross mgn60%
Net mgn11%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 March 2022
Declarations39 total
45,450 shares@ ₹350.684211.1% of flowEquity SharesSEBI:7b44e46e6ee249555dcb3809f062f27209ef52b0
Ideal exit: 16 Dec 2022 (T+270)
53,200 shares@ ₹330.081812.3% of flowEquity SharesSEBI:6c93527891d2065eb9a74c359c908a92c9ff60fa
Ideal exit: 11 Dec 2022 (T+270)
300,000 shares@ ₹323.419100.0% of flowEquity SharesSEBI:69c86e43d509cb7ad07af91fa9ff3f831b7d1cc8
Ideal exit: 9 Dec 2022 (T+270)
291,250 shares@ ₹320.789665.2% of flowEquity SharesSEBI:286771d5076760fe149bb2111c0338152f22f1eb
Ideal exit: 29 Nov 2022 (T+270)
52,000 shares@ ₹318.020511.4% of flowEquity SharesSEBI:0af2be3627c09e7fa760032f7f9ebe920aca4bf3
Ideal exit: 25 Nov 2022 (T+270)
1,550 shares@ ₹327.3065100.0% of flowEquity SharesSEBI:bc3c6e68d87cb728c3dc5735166c79e88641781d
Ideal exit: 21 Nov 2022 (T+270)
155,200 shares@ ₹321.5921100.0% of flowEquity SharesSEBI:886558ffe2f68a95a80a67b294fae2d78d3a58ad
Ideal exit: 21 Nov 2022 (T+270)
2,600 shares@ ₹639.7592100.0% of flowEquity SharesSEBI:da4da765acbf12a1efc02a7bcbec8077fe37f9e2
4,000 shares@ ₹628.850367.7% of flowEquity SharesSEBI:bb89d6aeb99a1b397593d54f772b4b40a519282f
2,500 shares@ ₹602.30100.0% of flowEquity SharesSEBI:d336305a1693c2b445e9a62f1997ae6e7478c30e
4,000 shares@ ₹301.00100.0% of flowEquity SharesSEBI:41a366a4c8db04da99e25821bfdf6d7a7c2a2bea
Ideal exit: 3 May 2022 (T+270)
3,750 shares@ ₹301.000.0000% mcap100.0% of flowEquity SharesSEBI:e8d76ac4b9005e038030bd8ecc4c171196962632
Ideal exit: 3 Jun 2022 (T+270)
3,750 shares@ ₹301.000.0000% mcap39.7% of flowEquity SharesSEBI:4f308a55bcecd1ca822cd6ad07991f38855c0941
Ideal exit: 3 Jun 2022 (T+270)
3,750 shares@ ₹301.000.0000% mcap28.8% of flowEquity SharesSEBI:43a75685095cb6fe8f5dc243b3c1243dacf97450
Ideal exit: 3 Jun 2022 (T+270)
3,750 shares@ ₹301.000.0000% mcap100.0% of flowEquity SharesSEBI:1478c8e242cf09836975e6560cf2d406f5026753
Ideal exit: 3 Jun 2022 (T+270)
4,000 shares@ ₹301.000.0000% mcap100.0% of flowEquity SharesSEBI:05255a66d070fc71fce0544ea378e9c1ee91e8b4
Ideal exit: 3 Jun 2022 (T+270)
20,000 shares@ ₹701.27120.0003% mcap100.0% of flowEquity SharesSEBI:36d17328b8f0f6e50fe1f3a41bd8c1310388bb52
2,500 shares@ ₹755.8960.0000% mcap100.0% of flowEquity SharesSEBI:449285e23e3f0b296482651a7b09c85585bbf6e7
3,750 shares@ ₹757.33090.0001% mcap71.2% of flowEquity SharesSEBI:c44a5a569cc57282acbe3344cbfadbeb8b3ef8ba
20,000 shares@ ₹269.700.0001% mcap49.8% of flowEquity SharesSEBI:8a4f4b71affa6d0c9a21cfeb56e0d360739d7fa8
Ideal exit: 27 Mar 2022 (T+270)
2,280 shares@ ₹766.39650.0000% mcap60.3% of flowEquity SharesSEBI:12bfeb5a913c22334278a88627fcd141a41ec583
57,869 sharesEquity SharesSEBI:626d1ecea5c5e7ca5c5ec4be6c7b466347d0e70e
Ideal exit: 21 Mar 2022 (T+270)
88,734 sharesEquity SharesSEBI:e2bf6e4ac4065df6c1c8fc0b1f112f91019d1ec6
25 of 39 declarations